StockVS

Cartesian Growth Corporation III (CGCT) Stock Analysis

Financial Services

Cartesian Growth Corporation III

$10.85

+$0.99 (+10.04%)

Last Updated: May 26, 2026

Price History

Analysis

Company Overview

Cartesian Growth Corporation III operates as a special purpose acquisition company (SPAC) dedicated to executing a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company functions within the Financial Services sector and specifically within the Shell Companies industry, which defines its status as an entity awaiting a primary business partner to form a combined public entity. Currently, the firm maintains a market capitalization of $353.62M, though its annual revenue is not reported, and the employee count is listed as N/A. These valuation figures indicate that the company holds a significant market presence relative to its lack of traditional operational revenue, a characteristic typical of shell companies that rely on future transaction values rather than current sales streams to define their scale.

Financial Health

The company reports a net income of $6.22M over the trailing twelve months, while revenue and EBITDA are not available, creating a scenario where the gap between reported revenue and net income cannot be quantified but suggests a reliance on non-operating income or specific transaction gains. The firm holds a cash balance of $624,163, yet it reports a negative free cash flow of $-244,656, indicating that its current operational activities consume more cash than it generates in the current reporting period. All three margin metrics—gross margin, operating margin, and profit margin—are recorded at 0.0%, which reflects the transitional nature of a shell company that has not yet commenced commercial operations to generate traditional sales-based profitability. When comparing liquidity resources, the company possesses $624,163 in cash against a debt level that is not available, resulting in a debt-to-equity ratio that is also not available, suggesting a balance sheet that lacks traditional leverage but faces liquidity constraints. The current ratio stands at 0.89, a figure below one that indicates the company's current assets are insufficient to cover its current liabilities without external financing or asset sales. Return on Equity is not available, while Return on Assets is -0.5%, a negative metric that reveals that the company's existing assets are currently generating a loss rather than value, a common characteristic for entities in the pre-merger phase.

Valuation Assessment

The trailing twelve-month P/E ratio is 41.00, whereas the forward P/E is not available, implying that the market is valuing the company based on historical earnings that may not reflect future earnings trajectories due to the lack of forward-looking financial data. The price-to-book ratio is -26.76, a negative figure that indicates the market is pricing the company significantly below its book value, a situation often driven by the negative net income and the specific accounting treatment of shell companies. Alternative valuation metrics such as the price-to-sales ratio and EV/EBITDA are not available, which prevents a standard revenue or enterprise value based comparison with traditional operating companies. The stock's recent trading range is defined by a 52-week high of $10.42 and a 52-week low of $10.00, meaning the current price sits within a very narrow band of volatility near the bottom of its yearly range. The beta value is not available, so the specific volatility of the stock relative to the broader market cannot be quantified based on the provided data.

Growth & Income

Revenue growth and earnings growth rates are both not available, preventing a direct comparison of whether earnings are growing faster or slower than revenue due to the absence of baseline revenue data for year-over-year calculations. As a non-dividend payer, the company does not distribute a dividend yield or a payout ratio, meaning it does not return capital to shareholders through dividends but instead retains earnings or available cash for potential future business combinations. The absence of a dividend payout ratio indicates that the company reinvests its financial resources, currently including its cash balance, into the pursuit of merger targets rather than paying out income. The overall growth and income profile is characterized by the lack of historical growth metrics and the absence of dividend distributions, reflecting the speculative nature of an entity focused on future business combinations rather than current operational performance.

Peer Comparison

Cartesian Growth Corporation III (CGCT) operates in the Shell Companies industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Cartesian Growth Corporation III CGCT $449.19M 36.2
Twenty One Capital, Inc. XXI $2.49B N/A
Churchill Capital Corp X CCCX $711.00M N/A
Drugs Made In America Acquisition II Corp. DMII $641.46M 77.5

The Shell Companies industry average P/E ratio is 82.8x. Cartesian Growth Corporation III trades at a P/E of 36.2.

This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.

About Cartesian Growth Corporation III

Cartesian Growth Corporation III does not have significant operations. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. Cartesian Growth Corporation III was incorporated in 2024 and is based in New York, New York.

Visit website →

Key Statistics

Market Cap
$449.19M
P/E Ratio
36.17
52-Week High
$10.93
52-Week Low
$9.26
Avg Volume
218.23K

Data provided by Yahoo Finance via yfinance. Updated daily.

Company Info

Exchange
NASDAQ
Country
United States